← Back to Search

Wearable Bioimpedance Analyzer for Obesity in Osteoarthritis

N/A

Waitlist Available

Research Sponsored by University of Iowa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months postoperatively

Awards & highlights

Study Summary

This trial aims to see if a wearable BIA wristband can help obese patients with osteoarthritis, who are seeking joint surgery, to safely lose body fat and gain muscle mass.

Who is the study for?

This trial is for adults with class III obesity (BMI > 40kg/m2) who are seeking joint replacement surgery and own a smartphone. It's not suitable for those unable to stand unsupported, have a pacemaker, or can't follow the study procedures.Check my eligibility

What is being tested?

The trial tests if wearing the InBody Band 2, a bioimpedance analyzer that tracks body composition changes, helps in gaining muscle mass and losing fat when combined with standard coaching compared to coaching alone.See study design

What are the potential side effects?

There are no direct side effects from using the InBody Band 2 itself as it is non-invasive. However, participants should be aware of general risks associated with changing diet and exercise routines.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months postoperatively

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months postoperatively

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of body composition changes

Secondary outcome measures

Body composition changes quantified

Surgical Outcomes

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Wearable Device GroupExperimental Treatment1 Intervention

Will be given InBody Band 2 to use while trying to achieve weight loss goal prior to total joint arthroplasty.

Group II: Control GroupActive Control1 Intervention

Will not be given InBody Band 2 to use while trying to achieve weight loss goal prior to total joint arthroplasty.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of IowaLead Sponsor

446 Previous Clinical Trials

879,412 Total Patients Enrolled

8 Trials studying Obesity

7,660 Patients Enrolled for Obesity

Media Library

Wearable Device Group Clinical Trial Eligibility Overview. Trial Name: NCT05986617 — N/A

Obesity Research Study Groups: Wearable Device Group, Control Group

Obesity Clinical Trial 2023: Wearable Device Group Highlights & Side Effects. Trial Name: NCT05986617 — N/A

Wearable Device Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05986617 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What implications does Wearable Device Group have for patient safety?

"The safety of Wearable Device Group is rated 3 due to its authorization as a Phase 4 trial, meaning it has already gained approval."

Answered by AI

Who is eligible to participate in this experiment?

"Candidates between 18 and 99 years old who have been diagnosed with obesity are eligible to join this clinical trial, which is seeking a total of 90 participants."

Answered by AI

Is this trial open to individuals aged 55 and above?

"To be eligible for this study, applicants must fall between the ages of 18 to 99. There are 215 clinical trials designed for those under 18 and 1253 specifically focused on seniors above 65 years old."

Answered by AI

Are there opportunities for volunteers to participate in this experiment?

"Unfortunately, the clinical trial listed on ClinicalTrials.gov is not currently enrolling patients at this time; although it was posted in July of 2023 and last updated in August of 2023. Fortunately, there are 1,657 other medical trials that are accepting participants right now!"

Answered by AI

Recent research and studies

Clinical Orthopaedics & Related ResearchJournal

Complication Rates After Hip or Knee Arthroplasty in Morbidly Obese Patients

Friedman, Richard J., Susanne Hess, Scott D. Berkowitz, and Martin Homering. 2013. “Complication Rates After Hip or Knee Arthroplasty in Morbidly Obese Patients”. Clinical Orthopaedics & Related Research. Ovid Technologies (Wolters Kluwer Health). doi:10.1007/s11999-013-3049-9.

clinicaltrials.govStudy

Wearable Bioimpedance Analyzer for Tracking Body Composition Changes

Jacob M. Elkins 2023. "Wearable Bioimpedance Analyzer for Tracking Body Composition Changes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05986617.

All > Knee Replacement